Central Pharmaceuticals (DHA:CENTRALPHL) Operating Cash Flow per Share : BDT-0.01 (TTM As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Central Pharmaceuticals Operating Cash Flow per Share?

Central Pharmaceuticals's operating cash flow per share for the three months ended in Sep. 2024 was BDT-0.01. Central Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2024 was BDT-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Central Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

During the past 12 years, Central Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was -35.40% per year. The lowest was -60.20% per year. And the median was -43.10% per year.

DHA:CENTRALPHL's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 8.85
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Central Pharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Central Pharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceuticals Operating Cash Flow per Share Chart

Central Pharmaceuticals Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.02

-0.01

-0.04

Central Pharmaceuticals Quarterly Data
	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-0.01

Competitive Comparison of Central Pharmaceuticals's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Central Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Central Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Central Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Central Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Central Pharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Central Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2024 is calculated as

Operating Cash Flow per Share (A: Jun. 2024 )	=	Cash Flow from Operations (A: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2024 )
	=	-4.574	/	119.801
	=	-0.04

Central Pharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Jun. 2024 is calculated as

Operating Cash Flow per Share (Q: Sep. 2024 )	=	Cash Flow from Operations (Q: Sep. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
	=	-0.515	/	113.285
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-0.01

Central Pharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Central Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Central Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceuticals Ltd (DHA:CENTRALPHL) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216

Website

https://www.centralphl.com

Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.

Central Pharmaceuticals Headlines

No Headlines